ArticleJournal for immunotherapy of cancer2022

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma.

Ivelina Spassova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.